Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
Simon Faissner(St. Josef-Hospital), V. Wee Yong(University of Calgary), Jason R. Plemel(University of Alberta), Ralf Gold(St. Josef-Hospital)
Cited by 456
Related Papers
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
|Brain|2011|1.2k
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
|Immunity|2015|919
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
|Cell|2020|627
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624